These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8357164)
1. Approaches for studying the pathogenic T cells in autoimmune patients. Willcox N; Baggi F; Batocchi AP; Beeson D; Harcourt G; Hawke S; Jacobson L; Matsuo H; Moody AM; Nagvekar N Ann N Y Acad Sci; 1993 Jun; 681():219-37. PubMed ID: 8357164 [TBL] [Abstract][Full Text] [Related]
2. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306 [TBL] [Abstract][Full Text] [Related]
3. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069 [TBL] [Abstract][Full Text] [Related]
4. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica). Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743 [TBL] [Abstract][Full Text] [Related]
5. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050 [TBL] [Abstract][Full Text] [Related]
7. Factors that determine the severity of experimental myasthenia gravis. Drachman DB; McIntosh KR; Yang B Ann N Y Acad Sci; 1998 May; 841():262-82. PubMed ID: 9668247 [TBL] [Abstract][Full Text] [Related]
11. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. Rosenberg JS; Oshima M; Atassi MZ J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433 [TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor. Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391 [TBL] [Abstract][Full Text] [Related]
13. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient. Baggi F; Nicolle M; Vincent A; Matsuo H; Willcox N; Newsom-Davis J J Neuroimmunol; 1993 Jul; 46(1-2):57-65. PubMed ID: 7689595 [TBL] [Abstract][Full Text] [Related]
14. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618 [TBL] [Abstract][Full Text] [Related]
15. Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis. Hohlfeld R; Toyka KV; Miner LL; Walgrave SL; Conti-Tronconi BM J Clin Invest; 1988 Mar; 81(3):657-60. PubMed ID: 2449458 [TBL] [Abstract][Full Text] [Related]
16. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931 [TBL] [Abstract][Full Text] [Related]
17. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor. Zhang YP; Tzartos SJ; Wekerle H Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice. Paas-Rozner M; Dayan M; Paas Y; Changeux JP; Wirguin I; Sela M; Mozes E Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2168-73. PubMed ID: 10681457 [TBL] [Abstract][Full Text] [Related]
19. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors. Bellone M; Ostlie N; Lei S; Conti-Tronconi BM Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694 [TBL] [Abstract][Full Text] [Related]
20. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients. Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]